Literature DB >> 21964756

Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia.

Jessica M Cassavaugh1, Sarah A Hale, Theresa L Wellman, Alan K Howe, Cheung Wong, Karen M Lounsbury.   

Abstract

Hypoxia inducible factor-1α (HIF-1α) stimulates expression of genes associated with angiogenesis and is associated with poor outcomes in ovarian and other cancers. In normoxia, HIF-1α is ubiquitinated and degraded through the E3 ubiquitin ligase, von Hippel-Lindau; however, little is known about the regulation of HIF-1α in hypoxic conditions. FBW7 is an E3 ubiquitin ligase that recognizes proteins phosphorylated by glycogen synthase kinase 3β (GSK3β) and targets them for destruction. This study used an ovarian cancer cell model to test the hypothesis that HIF-1α phosphorylation by GSK3β in hypoxia leads to interaction with FBW7 and ubiquitin-dependent degradation. Expression of constitutively active GSK3β reduced HIF-1α protein and transcriptional activity and increased ubiquitination of HIF-1α in hypoxia, whereas pharmacologic inhibition of GSK3 or expression of siGSK3β promoted HIF-1α stabilization and activity. A mechanism through FBW7 was supported by the observed decrease in HIF-1α stabilization when FBW7 was overexpressed and both the elevation of HIF-1α levels and decrease in ubiquitinated HIF-1α when FBW7 was suppressed. Furthermore, HIF-1α associated with FBW7γ by co-immunoprecipitation, and the interaction was weakened by inhibition of GSK3 or mutation of GSK3β phosphorylation sites. The relevance of this pathway to angiogenic signaling was supported by the finding that endothelial cell tube maturation was increased by conditioned media from hypoxic SK-OV-3 cell lines expressing suppressed GSK3β or FBW7. These data introduce a new mechanism for regulation of HIF-1α during hypoxia that utilizes phosphorylation to target HIF-1α for ubiquitin-dependent degradation through FBW7 and may identify new targets in the regulation of angiogenesis.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21964756      PMCID: PMC3202039          DOI: 10.1002/jcb.23321

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  41 in total

Review 1.  Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.

Authors:  Andreas Bikfalvi; Roy Bicknell
Journal:  Trends Pharmacol Sci       Date:  2002-12       Impact factor: 14.819

Review 2.  The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.

Authors:  Serge Y Fuchs; Vladimir S Spiegelman; K G Suresh Kumar
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

3.  Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study.

Authors:  Kathryn F McGonigle; Howard G Muntz; Jacqueline Vuky; Pamela J Paley; Dan S Veljovich; Benjamin E Greer; Barbara A Goff; Heidi J Gray; Thomas W Malpass
Journal:  Cancer       Date:  2011-02-24       Impact factor: 6.860

4.  Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling.

Authors:  Jung-Hyun Min; Haifeng Yang; Mircea Ivan; Frank Gertler; William G Kaelin; Nikola P Pavletich
Journal:  Science       Date:  2002-05-09       Impact factor: 47.728

5.  S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity.

Authors:  Inna M Yasinska; Vadim V Sumbayev
Journal:  FEBS Lett       Date:  2003-08-14       Impact factor: 4.124

6.  Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization.

Authors:  Mark A Gregory; Ying Qi; Stephen R Hann
Journal:  J Biol Chem       Date:  2003-10-16       Impact factor: 5.157

7.  Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling.

Authors:  Yan Dong; Soo Ok Lee; Haitao Zhang; James Marshall; Allen C Gao; Clement Ip
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

8.  VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer.

Authors:  Cheung Wong; Theresa L Wellman; Karen M Lounsbury
Journal:  Gynecol Oncol       Date:  2003-12       Impact factor: 5.482

9.  Sumoylation increases HIF-1alpha stability and its transcriptional activity.

Authors:  Seong-Hui Bae; Joo-Won Jeong; Jeong Ae Park; Se-Hee Kim; Moon-Kyoung Bae; Soo-Joon Choi; Kyu-Won Kim
Journal:  Biochem Biophys Res Commun       Date:  2004-11-05       Impact factor: 3.575

10.  Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells.

Authors:  Denis Mottet; Valéry Dumont; Yann Deccache; Catherine Demazy; Noelle Ninane; Martine Raes; Carine Michiels
Journal:  J Biol Chem       Date:  2003-05-22       Impact factor: 5.157

View more
  38 in total

1.  FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.

Authors:  Yan Song; Xinjia Zhou; Weiliang Bai; Xiulan Ma
Journal:  Tumour Biol       Date:  2015-01-14

Review 2.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

3.  Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cells.

Authors:  Yongqiang Chen; Elizabeth S Henson; Wenyan Xiao; Epsita Shome; Meghan B Azad; Teralee R Burton; Michelle Queau; Akshay Sathya; David D Eisenstat; Spencer B Gibson
Journal:  Cancer Biol Ther       Date:  2015-10-15       Impact factor: 4.742

Review 4.  Assessing the effects of threonyl-tRNA synthetase on angiogenesis-related responses.

Authors:  Adam C Mirando; Khadar Abdi; Peibin Wo; Karen M Lounsbury
Journal:  Methods       Date:  2016-11-12       Impact factor: 3.608

Review 5.  Recent advances in SCF ubiquitin ligase complex: Clinical implications.

Authors:  Nana Zheng; Quansheng Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-05-05

6.  MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7.

Authors:  Chi-Hsiang Chiang; Pei-Yi Chu; Ming-Feng Hou; Wen-Chun Hung
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

7.  F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.

Authors:  Kanae Yumimoto; Masaki Matsumoto; Ichiro Onoyama; Kazunori Imaizumi; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2013-08-16       Impact factor: 5.157

8.  Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids.

Authors:  Heung-Woo Park; Amber Dahlin; Szeman Tse; Qing Ling Duan; Brooke Schuemann; Fernando D Martinez; Stephen P Peters; Stanley J Szefler; John J Lima; Michiaki Kubo; Mayumi Tamari; Kelan G Tantisira
Journal:  J Allergy Clin Immunol       Date:  2014-01-31       Impact factor: 10.793

Review 9.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

10.  Overexpression of miR-223 Tips the Balance of Pro- and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy.

Authors:  Liwang Yang; Yutian Li; Xiaohong Wang; Xingjiang Mu; Dongze Qin; Wei Huang; Saeed Alshahrani; Michelle Nieman; Jiangtong Peng; Kobina Essandoh; Tianqing Peng; Yigang Wang; John Lorenz; Manoocher Soleimani; Zhi-Qing Zhao; Guo-Chang Fan
Journal:  J Biol Chem       Date:  2016-05-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.